AstraZeneca prepared to abandon efforts for U.S. authorization of COVID-19 vaccine - FT | Reuters
An AstraZeneca Plc executive said the British drugmaker would consider not submitting its COVID-19 vaccine for approval in the United States if the regulatory process takes too long, the Financial Times reported on Thursday.